Stemline Therapeutics, Inc.
1675 York Avenue
Suite 30-E
New York
New York
10128
United States
Tel: 212-831-1111
Website: http://www.stemline.com/
Email: info@stemline.com
139 articles about Stemline Therapeutics, Inc.
-
Stemline Reports Second Quarter 2017 Financial Results
8/8/2017
-
Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association
6/23/2017
-
Stemline Reports First Quarter 2017 Financial Results
5/11/2017
-
3rd Stemline Patient Died in Clinical Trial One Day Before $45 Million Public Offering
2/3/2017
-
Stemline Therapeutics, Inc. To Present At The Cowen and Company 36th Annual Health Care Conference
3/3/2016
-
Stemline Therapeutics, Inc. To Present At The 18th Annual BIO CEO & Investor Conference
2/4/2016
-
Stemline Therapeutics, Inc. To Present At The 34th Annual J.P. Morgan Healthcare Conference
1/5/2016
-
Stemline Therapeutics, Inc. Presents Clinical Update From Ongoing SL-401 Pivotal BPDCN Trial At The American Society of Hematology Annual Meeting
12/8/2015
-
Stemline Therapeutics, Inc. Announces Five Presentations, Including SL-401 Clinical Update From Ongoing Pivotal BPDCN Trial, At The Upcoming American Society of Hematology Annual Meeting
12/4/2015
-
Stemline Therapeutics, Inc. To Present At The Oppenheimer 26th Annual Healthcare Conference
12/3/2015
-
Stemline Therapeutics, Inc. Reports Third Quarter 2015 Financial Results
11/6/2015
-
Stemline Therapeutics, Inc. Announces Five Presentations At The American Society of Hematology Annual Meeting; SL-401 Poster Will Include Clinical Data From Lead-In And Ongoing Expansion Stages Of BPDCN Pivotal Trial
11/5/2015
-
Stemline Therapeutics, Inc. Announces SL-401 Receives EU Orphan Drug Designation For Treatment Of BPDCN
11/2/2015
-
Stemline Therapeutics, Inc. To Present At The Ladenburg Thalmann 2015 Healthcare Conference
9/29/2015
-
Stemline Therapeutics, Inc. Announces SL-401 Receives EU Orphan Drug Designation For Treatment Of Acute Myeloid Leukemia (AML)
9/10/2015
-
Stemline Therapeutics, Inc. To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
9/8/2015
-
Stemline Therapeutics, Inc. Reports Second Quarter 2015 Financial Results
8/11/2015
-
Stemline Therapeutics, Inc. To Present At The 2015 Wedbush Pacgrow Healthcare Conference
8/6/2015
-
Stemline Therapeutics, Inc. To Present At The JMP Securities Life Sciences Conference
6/23/2015
-
Stemline Therapeutics, Inc. To Present At The Jefferies and Co. 2015 Healthcare Conference
6/1/2015